FORTE BIOSCIENCES, INC. Net Change in Cash
FORTE BIOSCIENCES, INC. (FBRX) reported Net Change in Cash of -$27.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-12
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$18.73M, a 179.34% decline year-over-year.
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $23.61M.
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$6.68M.
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$5.20M.
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $54.71M.
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$14.88M.
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$3.98M.
- FORTE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$944.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$27.33M 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$18.73M 10-Q · filed 2026-05-11 | ||||||
| 2025-12-31 | $54.71M 10-K · filed 2026-03-31 | ||||||
| 2025-09-30 | $71.17M 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | $83.90M 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | $23.61M 10-Q · filed 2026-05-11 | ||||||
| 2024-12-31 | -$14.88M 10-K · filed 2026-03-31 | ||||||
| 2024-09-30 | -$20.76M 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | -$12.63M 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | -$6.68M 10-Q · filed 2025-05-15 | ||||||
| 2023-12-31 | -$3.98M 10-K · filed 2025-03-28 | ||||||
| 2023-09-30 | $5.08M 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | -$20.66M 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$5.20M 10-Q · filed 2024-05-13 | ||||||
| 2022-12-31 | -$944.00K 10-K · filed 2024-03-18 | ||||||
| 2022-09-30 | $2.00M 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | -$3.50M 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$2.01M 10-Q · filed 2023-05-15 | ||||||
| 2021-12-31 | -$16.72M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | -$13.10M 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$7.97M 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$4.00M 10-Q · filed 2022-05-16 | ||||||
| 2020-12-31 | $51.83M 10-K · filed 2022-03-31 | ||||||
| 2020-09-30 | $13.24M 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | $20.81M 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$2.82M 10-Q · filed 2021-05-10 | $5.25M 10-Q · filed 2020-04-23 | |||||
| 2019-12-31 | $1.92M 10-K · filed 2021-03-16 | -$31.83M 10-K · filed 2020-02-27 | |||||
| 2019-09-30 | $2.67M 10-Q · filed 2020-11-09 | -$15.23M 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | $3.29M 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | -$9.81M 10-Q · filed 2020-04-23 | ||||||
| 2018-12-31 | $4.88M 10-K · filed 2020-02-27 | ||||||
| 2018-09-30 | -$12.45M 10-Q · filed 2019-11-12 | ||||||
| 2017-12-31 | $30.42M 10-K · filed 2020-02-27 |